HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone.

Abstract
Antagonists of growth hormone-releasing hormone (GH-RH) inhibit the growth of various cancers by mechanism(s) that include the suppression of the insulin-like growth factors (IGF)-I and/or -II. In this study, nude mice bearing orthotopic implants of MDA-MB-435 human estrogen-independent breast carcinoma received 39 days of therapy with GH-RH antagonist JV-1-36 (20 microg/day). The treatment significantly inhibited tumor growth by 71.1% (p<0.01) and nullified the metastatic potential of MDA-MB-435 cells. Four of eight control mice (50%) developed metastases in the lymph nodes and one (12.5%) in the lung, but none of the animals receiving JV-1-36 showed metastatic spread. GH-RH antagonist JV-1-36 inhibited the growth of MDA-MB-435 cells in vitro, while IGF-I stimulated it. However, mRNA for IGF-I or -II was not detected in MDA-MB-435 cells, indicating that the suppression of autocrine IGFs may not be involved in the antiproliferative mechanism. Using ligand competition assays with (125)I-labeled GH-RH antagonist JV-1-42, specific high-affinity binding sites for GH-RH were found on tumor membranes. Reverse transcription-polymerase chain reaction revealed the expression of mRNA for GH-RH receptor splice variant-1 in MDA-MB-435 tumors. Our results suggest that the antitumorigenic action of GH-RH antagonists on MDA-MB-435 breast cancer could be direct and mediated by tumoral GH-RH receptors.
AuthorsI Chatzistamou, A V Schally, J L Varga, K Groot, R Busto, P Armatis, G Halmos
JournalAnti-cancer drugs (Anticancer Drugs) Vol. 12 Issue 9 Pg. 761-8 (Oct 2001) ISSN: 0959-4973 [Print] England
PMID11593058 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • JV 1-36
  • RNA, Messenger
  • Receptors, Growth Factor
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II
  • Growth Hormone-Releasing Hormone
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Breast Neoplasms (drug therapy, metabolism, pathology)
  • Cell Division (drug effects)
  • Female
  • Growth Hormone-Releasing Hormone (analogs & derivatives, antagonists & inhibitors, metabolism, pharmacology)
  • Humans
  • Insulin-Like Growth Factor I (metabolism)
  • Insulin-Like Growth Factor II (metabolism)
  • Mice
  • Mice, Nude
  • Neoplasm Metastasis
  • RNA, Messenger (analysis)
  • Receptors, Growth Factor (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: